Skip to Content

Clinical Trial Details


Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (HARMONEE)


Request Additional Trial Information
Full Trial Details:

Condition: Coronary Artery Disease
Study Type: Interventional
Phase: Phase III
Study Start Date: 05/05/2015
Study Completion Date: TBD

This study is intended to demonstrate that the Combo stent platform shows superiority to an imputed BMS performance goal, noninferior effectiveness and safety vs best-in-class second-generation everolimus-eluting stent, and evidence of mechanistic activity of the anti-CD34-Ab EPC capture technology with healthy level of intimal tissue coverage superior to that of the best-in-class EES.

NCT Number
Principal Investigator(s)
Thomas Wang, MD
Participant Eligibility
  • Age: 20 - No Maximum
  • Gender: Male, Female


  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!